Glycosinnovations Overview

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Glycosinnovations General Information

Description

Developer of carbohydrate drugs designed to treat inflammatory and allergic diseases. The company's drugs are used in the treatment of asthma and allergic rhinitis, enabling healthcare providers to treat the patients and cure them.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Australia
Primary Industry
Drug Discovery
Corporate Office
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glycosinnovations Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Aug-2016 Completed Startup
1. Early Stage VC Completed Startup
To view Glycosinnovations’s complete valuation and funding history, request access »

Glycosinnovations FAQs

  • Where is Glycosinnovations headquartered?

    Glycosinnovations is headquartered in Australia.

  • What industry is Glycosinnovations in?

    Glycosinnovations’s primary industry is Drug Discovery.

  • Is Glycosinnovations a private or public company?

    Glycosinnovations is a Private company.

  • What is Glycosinnovations’s current revenue?

    The current revenue for Glycosinnovations is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process